Kalkine has a fully transformed New Avatar.
Last update at 2025-06-09T19:02:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Trump to sign executive order boosting nuclear power use, Reuters says
Fri 23 May 25, 09:45 PMBWX Technologies, Inc. (BWXT) Completes $525M Acquisition of Kinectrics
Thu 22 May 25, 12:11 AMQ1 Earnings Roundup: BWX (NYSE:BWXT) And The Rest Of The Defense Contractors Segment
Tue 20 May 25, 03:32 AMBWXT Q1 Earnings Call: Strong Revenue Beat and Contract Wins Offset Margin Pressures
Mon 19 May 25, 12:08 PM3 Overrated Stocks Facing Headwinds
Thu 15 May 25, 04:36 AMHere's What We Like About BWX Technologies' (NYSE:BWXT) Upcoming Dividend
Wed 14 May 25, 11:30 AMBWX Technologies CFO, Executive VP to Step Down
Mon 12 May 25, 08:38 PMBWXT Announces Chief Financial Officer Transition
Mon 12 May 25, 12:15 PM1 Profitable Stock with Competitive Advantages and 2 to Think Twice About
Thu 08 May 25, 04:35 AMBWX Technologies, Inc. Just Recorded A 15% EPS Beat: Here's What Analysts Are Forecasting Next
Wed 07 May 25, 11:40 AMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 314.38M | 395.71M | 362.17M | 313.74M | 280.14M |
Minority interest | -0.42900M | 0.42M | 0.53M | 0.56M | 0.35M |
Net income | 238.19M | 305.87M | 278.67M | 244.12M | 226.96M |
Selling general administrative | 234.28M | 230.40M | 231.17M | 216.77M | 214.09M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 551.93M | 550.28M | 575.40M | 533.86M | 504.01M |
Reconciled depreciation | 73.84M | 69.08M | 60.67M | 61.72M | 60.10M |
Ebit | 348.57M | 345.85M | 358.55M | 325.52M | 308.03M |
Ebitda | 430.15M | 497.02M | 452.50M | 413.61M | 368.13M |
Depreciation and amortization | 81.58M | 151.17M | 93.95M | 88.09M | 60.10M |
Non operating income net other | -34.19400M | 49.87M | 3.62M | -11.77900M | -24.83200M |
Operating income | 348.57M | 345.85M | 358.55M | 325.52M | 304.98M |
Other operating expenses | 1924.72M | 1815.26M | 1793.48M | 1595.50M | 1525.19M |
Interest expense | 36.41M | 35.76M | 31.01M | 35.32M | 27.82M |
Tax provision | 75.76M | 89.42M | 82.98M | 69.06M | 52.84M |
Interest income | 0.76M | 0.42M | 0.52M | 0.94M | 2.48M |
Net interest income | -35.65200M | -35.34200M | -30.49600M | -34.37800M | -25.34400M |
Extraordinary items | - | - | - | - | 13.50M |
Non recurring | 5.52M | -3.53200M | -1.36100M | 2.82M | 0.06M |
Other items | - | - | - | - | - |
Income tax expense | 75.76M | 89.42M | 82.98M | 69.06M | 52.84M |
Total revenue | 2232.83M | 2124.07M | 2123.52M | 1894.92M | 1799.89M |
Total operating expenses | 243.82M | 241.46M | 245.36M | 234.44M | 229.31M |
Cost of revenue | 1680.90M | 1573.80M | 1548.12M | 1361.06M | 1295.88M |
Total other income expense net | -34.19400M | 49.87M | 3.62M | -11.77900M | 30.79M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 238.62M | 306.29M | 279.20M | 244.68M | 227.31M |
Net income applicable to common shares | 238.19M | 305.87M | 278.67M | 244.12M | 226.96M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 2747.07M | 2618.94M | 2501.38M | 2293.50M | 1908.91M |
Intangible assets | 185.51M | 193.61M | 185.55M | 192.75M | 191.39M |
Earning assets | - | - | - | - | - |
Other current assets | 36.92M | 55.04M | 47.72M | 44.26M | 41.46M |
Total liab | 1813.76M | 1870.58M | 1864.14M | 1675.73M | 1504.80M |
Total stockholder equity | 933.35M | 748.31M | 637.17M | 617.77M | 404.11M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 130.75M | 145.77M | 158.15M | 173.06M | 143.90M |
Common stock | 1.28M | 1.28M | 1.27M | 1.27M | 1.27M |
Capital stock | 1.28M | 1.28M | 1.27M | 1.27M | 1.27M |
Retained earnings | 2093.92M | 1932.97M | 1775.75M | 1549.95M | 1344.38M |
Other liab | - | 202.09M | 204.08M | 277.86M | 286.49M |
Good will | 297.02M | 293.17M | 285.50M | 283.71M | 275.50M |
Other assets | - | 67.75M | 69.71M | 104.51M | 113.29M |
Cash | 78.62M | 35.24M | 33.89M | 42.61M | 86.54M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 375.05M | 367.86M | 459.62M | 529.73M | 404.71M |
Current deferred revenue | 107.39M | 88.73M | 111.62M | 83.58M | 75.42M |
Net debt | 1151.28M | 1253.63M | 1155.41M | 908.82M | 737.61M |
Short term debt | 10.25M | 6.25M | - | 88.69M | 14.71M |
Short long term debt | 6.25M | 6.25M | - | 88.69M | 14.71M |
Short long term debt total | 1229.91M | 1288.87M | 1189.30M | 951.42M | 824.15M |
Other stockholder equity | -1154.38400M | -1164.00700M | -1151.99200M | -941.65200M | -934.09500M |
Property plant equipment | - | 1134.90M | 1045.64M | 816.47M | 580.24M |
Total current assets | 817.80M | 771.62M | 773.73M | 773.60M | 629.75M |
Long term investments | 98.10M | 108.30M | 85.28M | 71.81M | 70.12M |
Net tangible assets | - | 261.53M | 166.12M | 141.31M | -62.78800M |
Short term investments | 2.99M | 3.80M | 3.81M | 3.71M | 5.84M |
Net receivables | 674.86M | 674.61M | 685.42M | 679.96M | 492.85M |
Long term debt | 1203.42M | 1282.62M | 1189.30M | 862.73M | 809.44M |
Inventory | 27.40M | 2.93M | 2.90M | 3.07M | 3.06M |
Accounts payable | 126.65M | 127.11M | 189.84M | 184.39M | 170.68M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | 0.04M | 0.06M | 0.00200M | 0.00600M |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -7.46300M | -21.93000M | 12.14M | 8.20M | -7.44800M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | 1.28M | 1.27M | 1.27M | 1.27M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | 1932.97M | 1775.75M | 1549.95M | 1344.38M |
Treasury stock | - | - | -1326.28000M | -1095.45200M | -1068.16400M |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 57.28M | 96.77M | 94.72M | 96.40M | 95.60M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 1929.26M | 1847.32M | 1727.65M | 1519.90M | 1279.16M |
Capital lease obligations | - | - | - | - | - |
Long term debt total | - | 1282.62M | 1189.30M | 862.73M | 809.44M |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Investments | -168.14500M | -256.23600M | 0.81M | 2.13M | 1.67M |
Change to liabilities | - | -60.20700M | 30.92M | 6.76M | 26.62M |
Total cashflows from investing activities | - | -256.23600M | -304.65300M | -265.31900M | -179.99500M |
Net borrowings | - | 97.59M | 220.72M | 131.72M | 45.51M |
Total cash from financing activities | -169.37100M | 13.95M | -90.13600M | 25.05M | -43.71300M |
Change to operating activities | - | -76.79500M | -64.52100M | -23.14300M | -20.48600M |
Net income | 245.85M | 238.62M | 306.29M | 279.20M | 244.68M |
Change in cash | 40.62M | 1.22M | -8.52300M | -44.10200M | 55.99M |
Begin period cash flow | 40.99M | 39.77M | 48.30M | 92.40M | 36.41M |
End period cash flow | 81.61M | 40.99M | 39.77M | 48.30M | 92.40M |
Total cash from operating activities | 363.70M | 244.70M | 386.03M | 196.44M | 279.37M |
Issuance of capital stock | - | - | - | - | - |
Depreciation | 78.57M | 73.84M | 69.08M | 60.67M | 61.72M |
Other cashflows from investing activities | - | -57.93400M | 5.58M | -12.42000M | 0.46M |
Dividends paid | -84.97400M | 81.07M | 79.67M | 72.94M | 65.37M |
Change to inventory | - | - | -1.99100M | 6.84M | -14.13500M |
Change to account receivables | 0.46M | 19.36M | 87.88M | -106.88000M | 27.08M |
Sale purchase of stock | -7.59200M | -26.58800M | -230.82800M | -27.20900M | -29.19000M |
Other cashflows from financing activities | 4.45M | 999.81M | -7.22700M | -16.13500M | 0.90M |
Change to netincome | - | 23.83M | 47.08M | 21.80M | 8.55M |
Capital expenditures | 151.29M | 198.31M | 311.05M | 255.03M | 182.12M |
Change receivables | - | 15.17M | 84.01M | -98.30200M | 15.61M |
Cash flows other operating | - | -46.59400M | -155.56200M | -73.68000M | -78.77400M |
Exchange rate changes | - | - | - | - | 0.33M |
Cash and cash equivalents changes | - | 2.42M | -8.76300M | -43.83100M | 55.99M |
Change in working capital | -16.67500M | -141.50200M | -14.74100M | -174.77100M | -42.76700M |
Stock based compensation | 15.90M | 14.13M | 18.61M | 16.84M | 12.73M |
Other non cash items | 45.19M | 54.10M | -33.30500M | 6.61M | -0.78400M |
Free cash flow | 212.41M | 46.39M | 74.97M | -58.58500M | 97.24M |
Sector: Industrials Industry: Aerospace & Defense
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
BWXT BWX Technologies Inc |
3.54 2.73% | 133.26 | 40.46 | 36.76 | 4.17 | 10.88 | 4.74 | 26.38 |
BA The Boeing Company |
7.24 3.43% | 218.04 | - | 294.12 | 1.68 | - | 2.25 | 111.56 |
EADSY Airbus Group NV |
0.05 0.11% | 47.14 | 27.76 | 21.51 | 1.93 | 7.21 | 1.79 | 13.93 |
EADSF Airbus Group SE |
0.26 0.14% | 188.88 | 27.24 | 21.28 | 1.91 | 7.14 | 1.79 | 13.93 |
RTX Raytheon Technologies Corp |
0.88 0.63% | 139.98 | 38.65 | 15.77 | 1.77 | 1.69 | 2.22 | 16.02 |
BWX Technologies, Inc., together with its subsidiaries, manufactures and sells nuclear components in the United States, Canada, and internationally. It operates through two segments, Government Operations and Commercial Operations. The Government Operations segment designs and manufactures naval nuclear components, reactors, and nuclear fuel; fabrication activities; and supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers. This segment also involved in manufacture of close-tolerance and equipment for nuclear applications; down blend government stockpiles of uranium; receives, stores, characterizes, dissolves, recovers, and purifies uranium-bearing materials; and supplies research reactor fuel elements for colleges, universities, and national laboratories, as well as components for defense applications. The Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, and reactor components; and other auxiliary equipment, including containers for the storage of nuclear fuel and other high-level nuclear waste. This segment also offers nuclear fuel, fuel handling systems, tooling delivery systems, nuclear grade materials, and precisely machined components, and related services for CANDU nuclear power plants; provides in-plant inspection, maintenance, and modification services, as well as non-destructive examination and tooling/repair solutions; and manufactures medical radioisotopes, radiopharmaceuticals, and medical devices. The company was formerly known as The Babcock & Wilcox Company and changed its name to BWX Technologies, Inc. in June 2015. BWX Technologies, Inc. was founded in 1867 and is headquartered in Lynchburg, Virginia.
800 Main Street, Lynchburg, VA, United States, 24504
Name | Title | Year Born |
---|---|---|
Mr. Rex D. Geveden | Pres, CEO & Director | 1962 |
Mr. Robb A. LeMasters | Sr. VP & CFO | 1978 |
Mr. Thomas E. McCabe | Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. | 1955 |
Mr. Richard W. Loving | Special Advisor | 1956 |
Mr. Robert L. Duffy | Sr. VP & Chief Admin. Officer | 1967 |
Mr. Mark A. Kratz | VP of Investor Relations | NA |
Mr. John R. MacQuarrie | Pres of Commercial Operations Segment | NA |
Ms. Heatherly H. Dukes | Pres of BWXT Technical Services Group Inc | NA |
Ms. Suzanne C. Sterner | Sr. VP & Chief Corp. Affairs Officer | NA |
Dr. Jonathan W. Cirtain Ph.D. | Sr. VP, Chief Devel. Officer and Pres & CEO of BWXT Medical Ltd | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.